{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:51:41Z","timestamp":1774666301193,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10620-8","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:02:05Z","timestamp":1774663325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and imaging profiling of restrictive cardiomyopathies: insights into amyloid, sarcoid, and iron overload phenotypes"],"prefix":"10.1007","volume":"31","author":[{"given":"Syed","family":"Bukhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooq H.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Kelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joban","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha A.","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Hulten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"10620_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270\u2013276. https:\/\/doi.org\/10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"key":"10620_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","volume":"18","author":"G Habib","year":"2017","unstructured":"Habib G, Bucciarelli-Ducci C, Caforio ALP et al (2017) Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 18:1090\u20131121. https:\/\/doi.org\/10.1093\/ehjci\/jex034","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10620_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamacardio.2019.0052","volume":"4","author":"TH Marwick","year":"2019","unstructured":"Marwick TH, Shah SJ, Thomas JD (2019) Myocardial strain in the assessment of patients with heart failure: a review. JAMA Cardiol 4:287\u2013294. https:\/\/doi.org\/10.1001\/jamacardio.2019.0052","journal-title":"JAMA Cardiol"},{"key":"10620_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","volume":"121","author":"B Pilebro","year":"2016","unstructured":"Pilebro B, Suhr OB, Naslund U et al (2016) (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci 121:17\u201324. https:\/\/doi.org\/10.3109\/03009734.2015.1122687","journal-title":"Ups J Med Sci"},{"key":"10620_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cardfail.2021.09.015","volume":"28","author":"J Kozlitina","year":"2022","unstructured":"Kozlitina J, Garg S, Drazner MH et al (2022) Clinical implications of the amyloidogenic V122I transthyretin variant in the general population. J Card Fail 28:403\u2013414. https:\/\/doi.org\/10.1016\/j.cardfail.2021.09.015","journal-title":"J Card Fail"},{"key":"10620_CR6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/eurjpc\/zwae093","volume":"31","author":"A Aimo","year":"2024","unstructured":"Aimo A, Vergaro G, Castiglione V et al (2024) Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study. Eur J Prev Cardiol 31:1410\u20131417. https:\/\/doi.org\/10.1093\/eurjpc\/zwae093","journal-title":"Eur J Prev Cardiol"},{"key":"10620_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMc1917321","volume":"382","author":"S Ravichandran","year":"2020","unstructured":"Ravichandran S, Lachmann HJ, Wechalekar AD (2020) Epidemiologic and survival trends in amyloidosis, 1987\u20132019. N Engl J Med 382:1567\u20131568. https:\/\/doi.org\/10.1056\/NEJMc1917321","journal-title":"N Engl J Med"},{"key":"10620_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","volume":"2","author":"TP Quock","year":"2018","unstructured":"Quock TP, Yan T, Chang E, Guthrie S, Broder MS (2018) Epidemiology of AL amyloidosis: a real-world study using US claims data. Blood Adv 2:1046\u20131053. https:\/\/doi.org\/10.1182\/bloodadvances.2018016402","journal-title":"Blood Adv"},{"key":"10620_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1200\/OP.22.00396","volume":"19","author":"D Dima","year":"2023","unstructured":"Dima D, Mazzoni S, Anwer F et al (2023) Diagnostic and treatment strategies for AL amyloidosis in an era of therapeutic innovation. JCO Oncol Pract 19:265\u2013275. https:\/\/doi.org\/10.1200\/OP.22.00396","journal-title":"JCO Oncol Pract"},{"key":"10620_CR10","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood.2019000834","volume":"134","author":"R Manwani","year":"2019","unstructured":"Manwani R, Cohen O, Sharpley F et al (2019) A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib. Blood 134:2271\u20132280. https:\/\/doi.org\/10.1182\/blood.2019000834","journal-title":"Blood"},{"key":"10620_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","volume":"22","author":"A Milandri","year":"2020","unstructured":"Milandri A, Farioli A, Gagliardi C et al (2020) Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies. Eur J Heart Fail 22:507\u2013515. https:\/\/doi.org\/10.1002\/ejhf.1742","journal-title":"Eur J Heart Fail"},{"key":"10620_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jns.12451","volume":"26","author":"S Tozza","year":"2021","unstructured":"Tozza S, Severi D, Spina E et al (2021) The neuropathy in hereditary transthyretin amyloidosis: a narrative review. J Peripher Nerv Syst 26:155\u2013159. https:\/\/doi.org\/10.1111\/jns.12451","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10620_CR13","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.amjmed.2022.01.004","volume":"135","author":"S Law","year":"2022","unstructured":"Law S, Gillmore JD (2022) When to suspect and how to approach a diagnosis of amyloidosis. Am J Med 135(1):S2\u2013S8. https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.004","journal-title":"Am J Med"},{"key":"10620_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185588","author":"L Teresi","year":"2024","unstructured":"Teresi L, Trimarchi G, Liotta P et al (2024) Electrocardiographic patterns and arrhythmias in cardiac amyloidosis: from diagnosis to therapeutic management-a narrative review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13185588","journal-title":"J Clin Med"},{"key":"10620_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","volume":"6","author":"L De Michieli","year":"2024","unstructured":"De Michieli L, Cipriani A, Iliceto S, Dispenzieri A, Jaffe AS (2024) Cardiac troponin in patients with light chain and transthyretin cardiac amyloidosis: JACC: cardiooncology state-of-the-art review. JACC CardioOncol 6:1\u201315. https:\/\/doi.org\/10.1016\/j.jaccao.2023.12.006","journal-title":"JACC CardioOncol"},{"issue":"21","key":"10620_CR16","doi-asserted-by":"publisher","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","volume":"149","author":"RK Cheng","year":"2024","unstructured":"Cheng RK, Kittleson MM, Beavers CJ et al (2024) Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation 149(21):e1197. https:\/\/doi.org\/10.1161\/CIR.0000000000001240","journal-title":"Circulation"},{"key":"10620_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J et al (2015) Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 131:624\u2013632. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"10620_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","volume":"25","author":"DR Okada","year":"2018","unstructured":"Okada DR, Bravo PE, Vita T et al (2018) Isolated cardiac sarcoidosis: a focused review of an under-recognized entity. J Nucl Cardiol 25:1136\u20131146. https:\/\/doi.org\/10.1007\/s12350-016-0658-1","journal-title":"J Nucl Cardiol"},{"key":"10620_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","volume":"76","author":"A Yafasova","year":"2020","unstructured":"Yafasova A, Fosbol EL, Schou M et al (2020) Long-term adverse cardiac outcomes in patients with sarcoidosis. J Am Coll Cardiol 76:767\u2013777. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.038","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cardfail.2023.03.022","volume":"29","author":"C Duvall","year":"2023","unstructured":"Duvall C, Pavlovic N, Rosen NS et al (2023) Sex and race differences in cardiac sarcoidosis presentation, treatment and outcomes. J Card Fail 29:1135\u20131145. https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.022","journal-title":"J Card Fail"},{"key":"10620_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","volume":"28","author":"NA Gilotra","year":"2022","unstructured":"Gilotra NA, Griffin JM, Pavlovic N et al (2022) Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail 28:113\u2013132. https:\/\/doi.org\/10.1016\/j.cardfail.2021.06.016","journal-title":"J Card Fail"},{"key":"10620_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1536\/ihj.17-695","volume":"59","author":"T Kiko","year":"2018","unstructured":"Kiko T, Yoshihisa A, Kanno Y et al (2018) A multiple biomarker approach in patients with cardiac sarcoidosis. Int Heart J 59:996\u20131001. https:\/\/doi.org\/10.1536\/ihj.17-695","journal-title":"Int Heart J"},{"key":"10620_CR23","doi-asserted-by":"publisher","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","volume":"14","author":"LEM Eurelings","year":"2019","unstructured":"Eurelings LEM, Miedema JR, Dalm V et al (2019) Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One 14:e0223897. https:\/\/doi.org\/10.1371\/journal.pone.0223897","journal-title":"PLoS One"},{"key":"10620_CR24","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1002\/jcp.30219","volume":"236","author":"S Kumfu","year":"2021","unstructured":"Kumfu S, Siri-Angkul N, Chattipakorn SC, Chattipakorn N (2021) Silencing of lipocalin-2 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis. J Cell Physiol 236:5108\u20135120. https:\/\/doi.org\/10.1002\/jcp.30219","journal-title":"J Cell Physiol"},{"key":"10620_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJMoa041534","volume":"352","author":"PC Adams","year":"2005","unstructured":"Adams PC, Reboussin DM, Barton JC et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769\u20131778. https:\/\/doi.org\/10.1056\/NEJMoa041534","journal-title":"N Engl J Med"},{"key":"10620_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tracli.2023.04.001","volume":"30","author":"CLM de Roij van Zuijwijn","year":"2023","unstructured":"de Roij van Zuijwijn CLM, Westerweel PE, Schipperus MR et al (2023) Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: real-world data from a multicenter cohort study. Transfus Clin Biol 30:314\u2013318. https:\/\/doi.org\/10.1016\/j.tracli.2023.04.001","journal-title":"Transfus Clin Biol"},{"key":"10620_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","volume":"51","author":"LM Buja","year":"1971","unstructured":"Buja LM, Roberts WC (1971) Iron in the heart. Etiology and clinical significance. Am J Med 51:209\u2013221. https:\/\/doi.org\/10.1016\/0002-9343(71)90240-3","journal-title":"Am J Med"},{"key":"10620_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"Taher AT, Saliba AN (2017) Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program 2017:265\u2013271. https:\/\/doi.org\/10.1182\/asheducation-2017.1.265","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10620_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39 e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"10620_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","volume":"71","author":"NL Pereira","year":"2018","unstructured":"Pereira NL, Grogan M, Dec GW (2018) Spectrum of restrictive and infiltrative cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol 71:1130\u20131148. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.016","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ejhf.205","volume":"17","author":"E Joyce","year":"2015","unstructured":"Joyce E, Ninaber MK, Katsanos S et al (2015) Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail 17:51\u201362. https:\/\/doi.org\/10.1002\/ejhf.205","journal-title":"Eur J Heart Fail"},{"key":"10620_CR32","doi-asserted-by":"publisher","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","volume":"35","author":"SAM Cuddy","year":"2022","unstructured":"Cuddy SAM, Chetrit M, Jankowski M et al (2022) Practical points for echocardiography in cardiac amyloidosis. J Am Soc Echocardiogr 35:A31\u2013A40. https:\/\/doi.org\/10.1016\/j.echo.2022.06.006","journal-title":"J Am Soc Echocardiogr"},{"key":"10620_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","volume":"12","author":"PE Bravo","year":"2019","unstructured":"Bravo PE, Fujikura K, Kijewski MF et al (2019) Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of amyloid deposits. JACC Cardiovasc Imaging 12:1165\u20131173. https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/ehjci\/jead032","volume":"24","author":"J Abecasis","year":"2023","unstructured":"Abecasis J, Lopes P, Santos RR et al (2023) Prevalence and significance of relative apical sparing in aortic stenosis: insights from an echo and cardiovascular magnetic resonance study of patients referred for surgical aortic valve replacement. Eur Heart J Cardiovasc Imaging 24:1033\u20131042. https:\/\/doi.org\/10.1093\/ehjci\/jead032","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10620_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ehf2.13738","volume":"9","author":"D Kyrouac","year":"2022","unstructured":"Kyrouac D, Schiffer W, Lennep B et al (2022) Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing. ESC Heart Fail 9:385\u2013397. https:\/\/doi.org\/10.1002\/ehf2.13738","journal-title":"ESC Heart Fail"},{"key":"10620_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","volume":"32","author":"V Monivas Palomero","year":"2019","unstructured":"Monivas Palomero V, Durante-Lopez A, Sanabria MT et al (2019) Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr 32:845-853 e841. https:\/\/doi.org\/10.1016\/j.echo.2019.03.005","journal-title":"J Am Soc Echocardiogr"},{"key":"10620_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.resinv.2022.02.001","volume":"60","author":"K Tanizawa","year":"2022","unstructured":"Tanizawa K, Handa T, Nagai S et al (2022) Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis. Respir Investig 60:385\u2013392. https:\/\/doi.org\/10.1016\/j.resinv.2022.02.001","journal-title":"Respir Investig"},{"key":"10620_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s43044-024-00540-z","volume":"76","author":"K Raghuram","year":"2024","unstructured":"Raghuram K, Gopalakrishnan A, Nair KKM, Namboodiri N, Valaparambil A (2024) Left ventricular apical aneurysm in Takayasu arteritis and chronic active Epstein-Barr virus infection. Egypt Heart J 76:100. https:\/\/doi.org\/10.1186\/s43044-024-00540-z","journal-title":"Egypt Heart J"},{"key":"10620_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","volume":"20","author":"C Di Stefano","year":"2020","unstructured":"Di Stefano C, Bruno G, ArciniegasCalle MC et al (2020) Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis. BMC Cardiovasc Disord 20:21. https:\/\/doi.org\/10.1186\/s12872-019-01323-0","journal-title":"BMC Cardiovasc Disord"},{"key":"10620_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jacasi.2021.09.005","volume":"1","author":"K Kusano","year":"2021","unstructured":"Kusano K, Ishibashi K, Noda T et al (2021) Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings. JACC Asia 1:385\u2013395. https:\/\/doi.org\/10.1016\/j.jacasi.2021.09.005","journal-title":"JACC Asia"},{"key":"10620_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00408-015-9748-0","volume":"193","author":"K Tigen","year":"2015","unstructured":"Tigen K, Sunbul M, Karaahmet T et al (2015) Early detection of bi-ventricular and atrial mechanical dysfunction using two-dimensional speckle tracking echocardiography in patients with sarcoidosis. Lung 193:669\u2013675. https:\/\/doi.org\/10.1007\/s00408-015-9748-0","journal-title":"Lung"},{"key":"10620_CR42","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00516-2021","author":"H Ohira","year":"2022","unstructured":"Ohira H, Sato T, Manabe O et al (2022) Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00516-2021","journal-title":"ERJ Open Res"},{"key":"10620_CR43","doi-asserted-by":"publisher","unstructured":"(2022) European association for the study of the L. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol 77:479\u2013502. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.033","DOI":"10.1016\/j.jhep.2022.03.033"},{"key":"10620_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12947-022-00291-4","volume":"20","author":"A Attar","year":"2022","unstructured":"Attar A, Hosseinpour A, Hosseinpour H et al (2022) Global longitudinal strain for detection of cardiac iron overload in patients with thalassemia: a meta-analysis of observational studies with individual-level participant data. Cardiovasc Ultrasound 20:22. https:\/\/doi.org\/10.1186\/s12947-022-00291-4","journal-title":"Cardiovasc Ultrasound"},{"key":"10620_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186\u2013193. https:\/\/doi.org\/10.1161\/01.CIR.0000152819.97857.9D","journal-title":"Circulation"},{"key":"10620_CR46","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570\u20131579. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016567","journal-title":"Circulation"},{"key":"10620_CR47","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6:488\u2013497. https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36:244\u2013251. https:\/\/doi.org\/10.1093\/eurheartj\/ehu444","journal-title":"Eur Heart J"},{"key":"10620_CR49","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","volume":"12","author":"A Martinez-Naharro","year":"2019","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K et al (2019) Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging 12:810\u2013819. https:\/\/doi.org\/10.1016\/j.jcmg.2018.02.006","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34\u201339. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.978627","journal-title":"Circ Cardiovasc Imaging"},{"key":"10620_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","volume":"11","author":"A Martinez-Naharro","year":"2018","unstructured":"Martinez-Naharro A, Abdel-Gadir A, Treibel TA et al (2018) CMR-verified regression of cardiac AL amyloid after chemotherapy. JACC Cardiovasc Imaging 11:152\u2013154. https:\/\/doi.org\/10.1016\/j.jcmg.2017.02.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2025.10.054","volume":"87","author":"A Sheikh","year":"2026","unstructured":"Sheikh A, Achten A, Aimo A et al (2026) Myocardial amyloid burden in transthyretin amyloidosis. J Am Coll Cardiol 87:505\u2013518. https:\/\/doi.org\/10.1016\/j.jacc.2025.10.054","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR53","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","volume":"71","author":"T Kotecha","year":"2018","unstructured":"Kotecha T, Martinez-Naharro A, Treibel TA et al (2018) Myocardial edema and prognosis in amyloidosis. J Am Coll Cardiol 71:2919\u20132931. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.536","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR54","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A et al (2017) Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging 10:1437\u20131447. https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR55","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","volume":"45","author":"JP Smedema","year":"2005","unstructured":"Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683\u20131690. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.047","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4330\/wjc.v8.i9.496","volume":"8","author":"M Sano","year":"2016","unstructured":"Sano M, Satoh H, Suwa K et al (2016) Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy. World J Cardiol 8:496\u2013503. https:\/\/doi.org\/10.4330\/wjc.v8.i9.496","journal-title":"World J Cardiol"},{"key":"10620_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","volume":"16","author":"A Stevenson","year":"2023","unstructured":"Stevenson A, Bray JJH, Tregidgo L et al (2023) Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging 16:345\u2013357. https:\/\/doi.org\/10.1016\/j.jcmg.2022.10.018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR58","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","volume":"7","author":"PSS Athwal","year":"2022","unstructured":"Athwal PSS, Chhikara S, Ismail MF et al (2022) Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis. JAMA Cardiol 7:1057\u20131066. https:\/\/doi.org\/10.1001\/jamacardio.2022.2981","journal-title":"JAMA Cardiol"},{"key":"10620_CR59","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1007\/s00330-020-06765-1","volume":"30","author":"L Flamee","year":"2020","unstructured":"Flamee L, Symons R, Degtiarova G et al (2020) Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Eur Radiol 30:3702\u20133710. https:\/\/doi.org\/10.1007\/s00330-020-06765-1","journal-title":"Eur Radiol"},{"key":"10620_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1148\/radiol.2017162732","volume":"285","author":"VO Puntmann","year":"2017","unstructured":"Puntmann VO, Isted A, Hinojar R et al (2017) T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology 285:63\u201372. https:\/\/doi.org\/10.1148\/radiol.2017162732","journal-title":"Radiology"},{"key":"10620_CR61","doi-asserted-by":"publisher","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","volume":"9","author":"R Blankstein","year":"2016","unstructured":"Blankstein R, Waller AH (2016) Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging 9:e000867. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000867","journal-title":"Circ Cardiovasc Imaging"},{"key":"10620_CR62","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171\u20132179. https:\/\/doi.org\/10.1053\/euhj.2001.2822","journal-title":"Eur Heart J"},{"key":"10620_CR63","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","volume":"120","author":"P Kirk","year":"2009","unstructured":"Kirk P, Roughton M, Porter JB et al (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120:1961\u20131968. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.874487","journal-title":"Circulation"},{"key":"10620_CR64","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/jmri.24727","volume":"41","author":"DM Sado","year":"2015","unstructured":"Sado DM, Maestrini V, Piechnik SK et al (2015) Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J Magn Reson Imaging 41:1505\u20131511. https:\/\/doi.org\/10.1002\/jmri.24727","journal-title":"J Magn Reson Imaging"},{"key":"10620_CR65","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00330-022-09120-8","volume":"33","author":"A Meloni","year":"2023","unstructured":"Meloni A, Pistoia L, Positano V et al (2023) Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. Eur Radiol 33:1266\u20131276. https:\/\/doi.org\/10.1007\/s00330-022-09120-8","journal-title":"Eur Radiol"},{"key":"10620_CR66","doi-asserted-by":"publisher","first-page":"e010249","DOI":"10.1161\/CIRCIMAGING.119.010249","volume":"13","author":"A Masri","year":"2020","unstructured":"Masri A, Bukhari S, Ahmad S et al (2020) Efficient 1-Hour Technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging 13:e010249. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.010249","journal-title":"Circ Cardiovasc Imaging"},{"key":"10620_CR67","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s12350-018-1235-6","volume":"26","author":"C Rapezzi","year":"2019","unstructured":"Rapezzi C, Gagliardi C, Milandri A (2019) Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. J Nucl Cardiol 26:1638\u20131641. https:\/\/doi.org\/10.1007\/s12350-018-1235-6","journal-title":"J Nucl Cardiol"},{"key":"10620_CR68","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","volume":"25","author":"MA Stats","year":"2016","unstructured":"Stats MA, Stone JR (2016) Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Cardiovasc Pathol 25:413\u2013417. https:\/\/doi.org\/10.1016\/j.carpath.2016.07.001","journal-title":"Cardiovasc Pathol"},{"key":"10620_CR69","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46:1076\u20131084. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.073","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR70","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133:2404\u20132412. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"10620_CR71","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11886-024-02114-6","volume":"26","author":"AJ Romero Pabon","year":"2024","unstructured":"Romero Pabon AJ, Clerc OF, Vijayakumar S, Cuddy SAM, Dorbala S (2024) Recent advances in positron emission tomography radiotracers to image cardiac amyloidosis. Curr Cardiol Rep 26:1153\u20131162. https:\/\/doi.org\/10.1007\/s11886-024-02114-6","journal-title":"Curr Cardiol Rep"},{"key":"10620_CR72","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","volume":"13","author":"SAM Cuddy","year":"2020","unstructured":"Cuddy SAM, Bravo PE, Falk RH et al (2020) Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging 13:1325\u20131336. https:\/\/doi.org\/10.1016\/j.jcmg.2020.02.025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"SP Lee","year":"2015","unstructured":"Lee SP, Lee ES, Choi H et al (2015) 11C-pittsburgh b PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging 8:50\u201359. https:\/\/doi.org\/10.1016\/j.jcmg.2014.09.018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR74","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","volume":"16","author":"OF Clerc","year":"2023","unstructured":"Clerc OF, Cuddy SAM, Robertson M et al (2023) Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-florbetapir: a pilot PET\/CT study. JACC Cardiovasc Imaging 16:1419\u20131432. https:\/\/doi.org\/10.1016\/j.jcmg.2023.07.007","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR75","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W et al (2017) Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 58:1341\u20131353. https:\/\/doi.org\/10.2967\/jnumed.117.196287","journal-title":"J Nucl Med"},{"key":"10620_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","volume":"10","author":"MJ Kruse","year":"2017","unstructured":"Kruse MJ, Kovell L, Kasper EK et al (2017) Myocardial blood flow and inflammatory cardiac sarcoidosis. JACC Cardiovasc Imaging 10:157\u2013167. https:\/\/doi.org\/10.1016\/j.jcmg.2016.09.023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR77","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jcmg.2024.05.013","volume":"17","author":"TS Kafil","year":"2024","unstructured":"Kafil TS, Shaikh OM, Fanous Y et al (2024) Risk stratification in cardiac sarcoidosis with cardiac positron emission tomography: a systematic review and meta-analysis. JACC Cardiovasc Imaging 17:1079\u20131097. https:\/\/doi.org\/10.1016\/j.jcmg.2024.05.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR78","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A et al (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 19:757\u2013767. https:\/\/doi.org\/10.1093\/ehjci\/jex340","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10620_CR79","doi-asserted-by":"publisher","first-page":"e222483","DOI":"10.1148\/radiol.222483","volume":"307","author":"M Aitken","year":"2023","unstructured":"Aitken M, Davidson M, Chan MV et al (2023) Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis. Radiology 307:e222483. https:\/\/doi.org\/10.1148\/radiol.222483","journal-title":"Radiology"},{"key":"10620_CR80","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Groschel J et al (2025) 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J 46:3952\u20134041. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf192","journal-title":"Eur Heart J"},{"key":"10620_CR81","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","volume":"87","author":"MM Kittleson","year":"2026","unstructured":"Kittleson MM, Ambardekar AV et al (2026) Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC concise clinical guidance. J Am Coll Cardiol 87:549\u2013565. https:\/\/doi.org\/10.1016\/j.jacc.2025.09.004. (Writing)","journal-title":"J Am Coll Cardiol"},{"key":"10620_CR82","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","volume":"13","author":"MB Musumeci","year":"2020","unstructured":"Musumeci MB, Cappelli F, Russo D et al (2020) Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis. JACC Cardiovasc Imaging 13:1314\u20131321. https:\/\/doi.org\/10.1016\/j.jcmg.2019.10.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10620_CR83","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ejhf.3545","volume":"27","author":"H Malkonen","year":"2025","unstructured":"Malkonen H, Lehtonen J, Poyhonen P et al (2025) Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Eur J Heart Fail 27:488\u2013497. https:\/\/doi.org\/10.1002\/ejhf.3545","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10620-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:02:06Z","timestamp":1774663326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10620-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10620"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10620-8","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant disclosures related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}